Bliss Gvs Pharma has informed that subject to approval of shareholders in ensuing 39th Annual General Meeting and based on recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company through circular resolution approved on June 22, 2024 have appointed Dr. Nandkumar Kashinath Chodankar (DIN:02736718) as a Additional Director in the category of Non-Executive Independent Director of the Company for a period of 5 yrs with effective from June 22, 2024.
The above information is a part of company’s filings submitted to BSE.
